Skip to content

A study to find the incidence of surgical site infection in cesarean delivery,

impact of an evidence based surgical bundle on surgical site infection in cesarean delivery -a randomized contol trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029246
Enrollment
131
Registered
2020-11-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O85- Puerperal sepsis Health Condition 2: O989- Unspecified maternal infectious and parasitic disease complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: inj azithromycin ,antiseptic chlorhexidine .: injection azithromycin 500 mg stat, l/a of chlorhexidine to reduce ssi Control Intervention1: intervention,injection azithromycin, chlorhe

Sponsors

Kle hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: women admitted to obsteric ward and free labor room and who will undergo elective and emergency cesarean section for some obsteric indications

Exclusion criteria

Exclusion criteria: antenatal women with prom and features of chorioamnionitis ,gdm, severe anemia , aph ,immunosuppressed individuals .

Design outcomes

Primary

MeasureTime frame
To analyse whether evidence based surgical bundle is better than the standard routine care for prevention of cesarean section related SSITimepoint: To analyse whether evidence based surgical bundle is better than the standard routine care for prevention of cesarean section related SSI on post operative day 10

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactAditya

Department of obstetrics and gynecolgy Jawaharlal nehru medical college

romiarif@gmail.com9964892744

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 6, 2026